Abstract
Over 3000 marrow transplants are now carried out yearly, a number that will surely increase as long-term survival after marrow grafting improves. Patients are returning to their community physicians having been “cured” of their original diseases but suffering the sequelae of the marrow transplant procedure. On another plane, it is of great interest that marrow Transplantation creates intestinal and liver diseases that are similar to several puzzling, naturally occurring human illnesses. For example, acute graft-versus-host disease (GVHD) causes a form of inflammatory bowel disease that is most prominent in the ileocecal region. Chronic graft-versus-host disease in the liver looks much like primary biliary cirrhosis, and in the esophagus, like epidermolysis bullosa. This chapter will summarize the clinical presentation and pathophysiology of intestinal and liver injury after Transplantation, especially that mediated by the immune system.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Storb R, Thomas ED. Allogeneic bone marrow Transplantation. Immunol Rev 1983;71:77–102.
Storb R, Thomas ED, Buckner CD et al. Marrow Transplantation for aplastic anemia. Semin Hematol 1984;21:27–35.
O’Reilly RJ, Brochstein J, Dinsmore R, Kirkpatrick D. Marrow Transplantation for congenital disorders. Semin Hematol 1984;21:188–221.
Martin PJ, Hansen JA, Storb R, Thomas ED. Human marrow Transplantation: an immunological perspective. Adv Immunol 1987;40:379–438.
Parkman R. The application of bone marrow Transplantation to the treatment of genetic diseases. Science 1986;232:1373–1378.
McDonald GB, Shulman HM, Sullivan KM, Spencer GD. Intestinal and hepatic complications of human bone marrow Transplantations. Gastroenterology 1986;90:460–477, 770–784.
McDonald GB, Shulman HM, Wolford JL, Spencer GD. Liver disease after human marrow Transplantation. Semin Liver Dis 1987;7:210–229.
Ferrara JLM. Syngeneic graft-vs-host disease. Arch Dermatol 1987;123:741–742.
Deeg HJ, Storb R. Acute and chronic graft-versus-host disease: clinical manifestations, prophylaxis, and treatment. J Natl Cancer Inst 1986;76:1325–1328.
Neudorf S, Filipovich A, Ramsay NKC, Kersey J. Prevention and treatment of acute graft-versus-host disease. Semin Hematol 1984;21:91–100.
Storb R, Deeg HJ, Whitehead J et al. Marrow Transplantation for leukemia: A controlled trial of a combination of methotrexate and cyclosporine versus cyclosporin alone for prophylaxis of acute graft-versus-host disease. N Engl J Med 1986;314:729–735.
Storb R, Deeg HJ, Farewell V et al. Marrow Transplantation for severe aplastic anemia: Methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease. Blood 1986;68:119–125.
Sullivan KM, Deeg HJ, Sanders J et al. Hyperacute graft-versus-host disease in patients not given immunosuppression after allogeneic marrow Transplantation. Blood 1986;67:1172–1175.
Witherspoon RP, Lum LG, Storb R. Immunologic reconstitution after human marrow grafting. Semin Hematol 1984;21:2–10.
Atkinson K, Farewell V, Storb R et al. Analysis of late infections after human bone marrow Transplantation. Role of genotypic nonidentity between marrow donor and recipient and of nonspecific suppressor cells in patients with chronic graft-versus-host disease. Blood 1982;60:714–720.
Sullivan KM. Graft-versus-host disease. In: Clinical Bone Marrow Transplantation (Blume KG, Petz LD, eds). New York: Churchill Livingstone, 1983, pp. 91–129.
Glucksberg H, Storb R, Fefer A et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-matched sibling donors. Transplantation 1974;18:295–304.
Weiden PL, The Seattle Marrow Transplant Team. Graft-versus-host disease in allogeneic marrow Transplantation. In: Biology of Bone Marrow Transplantation (Gale RP, Fox DF, eds). New York: Academic Press, 1980, pp. 37–48.
Sullivan KM. Acute and chronic graft-versus-host disease in man. Int J Cell Cloning 1986;4:42–93.
Weisdorf SA, Salati LM, Longsdorf JA et al. Graft-versus-host disease of the intestine: A protein losing enteropathy characterized by fecal alpha1-antitrypsin. Gastroenterology 1983;85:1076–1081.
Spencer GD, Hackman RC, McDonald GB et al. A prospective study of unexplained nausea and vomiting after marrow Transplantation. Transplantation 1986;42:602–607.
Fisk JD, Shulman HM, Greening RR, McDonald GB, Sale GE, Thomas ED. Gastrointestinal radiographic features of human graft-versus-host disease. Am J Roentgenol 1981;136:329–336.
Maile CW, Frick MP, Crass JR et al. The plain abdominal radiograph in acute intestinal graft-versus-host disease. Am J Roentgenol 1985;145:289–292.
Spencer GD, Shulman HM, Myerson D, Thomas ED, McDonald GB. Diffuse intestinal ulceration after marrow Transplantation: A clinical-pathological study of 13 patients. Hum Pathol 1986;17:621–633.
Epstein RJ, McDonald GB, Sale GE, Shulman HM, Thomas ED. The diagnostic accuracy of the rectal biopsy in acute graft-versus-host disease: A prospective study of thirteen patients. Gastroenterology 1980;78:764–771.
Snover DC, Weisdorf SA, Vercellotti GM et al. A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow Transplantation. Hum Pathol 1985;16:387–392.
McDonald GB, Sale GE. The human gastrointestinal tract after allogeneic marrow Transplantation. In: The Pathology of Bone Marrow Transplantation (Sale GE, Shulman HM, eds). New York: Masson, 1984, pp. 77–103.
Gallucci BB, Sale GE, McDonald GB, Epstein R, Shulman HM, Thomas ED. The fine structure of human rectal epithelium in acute graft-versus-host disease. Am J Surg Pathol 1982;6:293–305.
Podack ER. The molecular mechanism of lymphocyte-mediated tumor cell lysis. Immunol Today 1985;6:21–27.
Otto HF. The interepithelial lymphocytes of the intestine. Morphological observations and immunological aspects of intestinal enteropathy. In: Current Topics of Pathology, Vol 57 (Altmann KW et al, eds). Berlin: Springer-Verlag, 1973, pp. 81–121.
Kotler DP,Gaetz HP, Lange M, Klein EB, Holt PR. Enteropathy associated with the acquired immunodeficiency syndrome. Ann Intern Med 1984;101:421–428.
Snover DC, Filipovich AH, Ramsay NKC, Weisdorf SA, Kersey JH. Graft-versus-host disease-like histopathological findings in pre-bone-marrow Transplantation biopsies of patients with severe T cell deficiency. Transplantation 1985;39:95–97.
Snover DC. Mucosal damage simulating acute graft-versus-host-reaction in cytomegalovirus colitis. Transplantation 1984;39:669–670.
Duly SA, Sloane JP. Changes in rectal leucocytes after allogeneic bone marrow Transplantation. Clin Exp Immunol 1987;67:151–158.
Beschorner WE, Yardley JH, Tutschka P, Santos G. Deficiency of intestinal immunity with graft-versus-host disease in humans. J Infect Dis 1981;144:38–46.
Kolb H, Sale GE, Lerner KG, Storb R, Thomas ED. Pathology of acute graft-versus-host disease in the dog. An autopsy study of ninety-five dogs. Am J Pathol 1979;96:581–594.
Weisdorf SA, Platt JL, Snover DC, Kersey JH, Scharp HL. In situ analysis of T and killer lymphocyte subpopulations in rectal biopsies from bone marrow transplant patients. Gastroenterology 1983;84:1348 (abstract).
Filipovich AH, McGlave PB, Ramsay NKC et al. Pretreatment of donor bone marrow with monoclonal antibody OKT3 for prevention of acute graft-versus-host disease in allogeneic histocompatible bone-marrow Transplantation. Lancet 1982;1:1266–1269.
Prentice HG, Blacklock HA, Janossy G et al. Use of anti-T-cell monoclonal antibody OKT3 to prevent acute graft-versus-host disease in allogeneic bone-marrow Transplantation for acute leukaemia. Lancet 1982;1:700–703.
Grebe SC, Streilein JW. Graft-versus-host reactions: A review. Adv Immunol 1976;22:119–221.
Elson CO, Reilly RW, Rosenberg IH. Small intestinal injury in the graft-versus-host reaction: An innocent bystander phenomenon. Gastroenterology 1977;72:886–889.
Gallucci BB, Shulman HM, Sale GE, Lerner KG, Caldwell LE, Thomas ED. The ultrastructure of the human epidermis in chronic graft-versus-host disease. AM J Pathol 1979;95:643–662.
van Bekkum DW, Knaan S. Role of bacterial microflora in development of intestinal lesions from graft-versus-host reaction. J Natl Cancer Inst 1977;58:787–790.
Pollard M, Chang CF, Strivastava KK. The role of microflora in development of graft-versus-host disease. Trans Proc 1976;4:533–536.
Mee AS, McLaughlin JE, Hodgson HJF, Jewell DP. Chronic immune colitis in rabbits. Gut 1790;20:1–5.
Storb R, Prentice RL, Buckner CD et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protected environment. N Engl J Med 1983;308:302–307.
Farthing MJG, Clark ML, Sloane JP et al. Liver disease after bone marrow Transplantation. Gut 1982;23:465–474.
Shulman HM, McDonald GB. Liver disease after marrow Transplantation. In: The Pathology of Bone Marrow Transplantation (Sale GE, Shulman HM, eds). New York: Masson, 1984, pp. 104–135.
Snover DC, Weisdorf SA, Ramsay NK et al. Hepatic graft-versus-host disease: A study of the predictive value of liver biopsy in diagnosis. Hepatology 1984;4:123–130.
Shulman HM, Sharma P, Amos D et al. A coded histologic study of hepatic graft-versus-host disease after human bone marrow Transplantation. Hepatology 1988;8:463–470.
Tanaka M, Umihara J, Chiba S, Ishikawa E. Intrahepatic bile duct injury following bone marrow Transplantation. Analysis of pathological features based on three-dimensional and his-tochemical observation. Acta Pathol J 1986;36:1793–1806.
Sloane JP, Farthing MJ, Powles RL. Histopathological changes in the liver after allogeneic bone marrow Transplantation. J Clin Pathol 1980;33:344–350.
Dilly SA, Sloane JP. An immunohistological study of human hepatic graft-versus-host disease. Clin Exp Immunol 1985;62:545–553.
Bernuau D, Gisselbrecht C, Devergie A et al. Histological and ultrastructural appearance of the liver graft-versus-host disease complicating bone marrow Transplantation. Transplantation 1980;29:236–244.
Searle J, Kerr JFR, Battersby C et al. An electron microscopic study of the mode of donor cell death in unmodified rejection of pig liver allografts. Aust J Exp Biol Med Sci 1977;55:401–406.
Shearer GM, Levy RB. Graft-versus-host-associated immune suppression is activated by recognition of allogeneic murine I-A antigens. J Exp Med 1983;157:936–946.
Suitters AJ, Lampert IA. Class II antigen induction in the liver of rats with graft-versus-host disease. Transplantation 1984;38:194–196.
Takacs L, Szende B, Rot AS et al. Expression of MHC Class II antigens on bile duct epithelium in experimental graft-versus-host disease. Clin Exp Immunol 1985;60:449–456.
Szetein MB, Steeg PS, Johnson HM, Oppenheim JJ. Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons. J Clin Invest 1984;73:556–565.
Walker EB, Maino V, Sanchez-Lanier M et al. Murine gamma interferon activates the release of a macrophage-derived Ia-inducing factor that transfers la inductive capacity. J Exp Med 1984;159:1532–1547.
Lautenschlager I, Taskinen E, Inkinen K et al. Distribution of the major histocompatibility complex antigens on different cellular components of human liver. Cell Immunol 1984;85:191–200.
Ballardini G, Bianchi FB, Doniach D et al. Aberrant expression of HLA-DR antigens on bile duct epithelium in primary biliary cirrhosis: Relevance to pathogenesis. Lancet 1984;2:1009–1113.
Takacs L, Szende B, Monostori E et al. Expression of HLA-DR antigens on bile duct cells of rejected liver transplant. Lancet 1983;2:1500 (letter).
McDonald GB, Jewell DP. Class II antigen (HLA-DR) expression by intestinal epithelial cells in inflammatory disease of the colon. J Clin Pathol 1984;40:312–317.
Sullivan KM, Shulman HM, Storb R et al. Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 1981;57:267–276.
Storb R, Prentice R, Sullivan KM et al. Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow Transplantation from HLA-identical siblings. Ann Intern Med 1983;98:461–466.
McDonald GB, Sullivan KM, Schuffler MD, Shulman HM, Thomas ED. Esophageal abnormalities in chronic graft-versus-host disease in humans. Gastroenterology 1981;80:914–921.
McDonald GB, Sullivan KM, Plumley TP. Radiographic features of esophageal involvement in chronic graft-versus-host disease. Am J Roentgenol 1984;142:501–506.
Johnston DE, Koehler RE, Balfe DM. Clinical manifestations of epidermolysis bullosa dystrophica. Dig Dis Sci 1981;26:1144–1149.
Agha FP, Raji MR. Esophageal involvement in pemphigoid: Clinical and roentgen manifestations. Gastrointest Radiol 1982;7:109–112.
Shulman HM, Sullivan KM, Weiden PL et al. Chronic graft-versus-host syndrome in man. A long-term clinico-pathologic study of 20 Seattle patients. Am J Med 1980;68:204–217.
Tsoi MS. Immunological mechanisms of graft-versus-host disease in man. Transplantation 1982;33:459–464.
Ralph DD, Springmeyer SC, Sullivan KM et al. Rapidly progressive air flow obstruction in marrow transplant recipients: Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Resp Dis 1984;129:641–644.
Schubert MM, Sullivan KM, Morton TH et al. Oral manifestations of chronic graft-versus-host disease. Arch Intern Med 1984;144:1591–1595.
Yau JC, Zander AR, Srigley JR et al. Chronic graft-versus-host disease complicated by mi-cronodular cirrhosis and esophageal varices. Transplantation 1986;41:129–130.
Knapp AB, Crawford JM, Rappeport JM, Gollan JL. Cirrhosis as a consequence of graft-versus-host disease. Gastroenterology 1987;92:513–519.
McDonald GB, Sharma P, Matthews DE et al. Venocclusive disease of the liver after bone marrow Transplantation: Diagnosis, incidence, and predisposing factors. Hepatology 1984;4:116–122.
Wulff JC, Santner TJ, Storb R et al. Transfusion requirements after HLA-identical marrow Transplantation in 82 patients with aplastic anemia. Vox Sang 1983;44:366–374.
Poulsen H, Christoffersen P. Abnormal bile duct epithelium in chronic aggressive hepatitis and cirrhosis. Hum Pathol 1972;3:217–225.
Bianchi L, Desmet VJ, Popper H et al. Histologic patterns of liver disease in hemophiliacs, with special reference to morphologic characteristics of non-A, non-B hepatitis. Semin Liv Dis 1987;7:203–209.
Izutsu KT, Sullivan KM, Schubert MM et al. Disordered salivary immunoglobulin secretion and sodium transport in human chronic graft-versus-host disease. Transplantation 1983;35:441–446.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1989 Plenum Publishing Corporation
About this chapter
Cite this chapter
McDonald, G.B. (1989). Immunological Injury to the Intestine and Liver in Human Marrow Transplant Recipients. In: Shaffer, E., Thomson, A.B.R. (eds) Modern Concepts in Gastroenterology Volume 2. Topics in Gastroenterology. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0781-5_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0781-5_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-8079-8
Online ISBN: 978-1-4613-0781-5
eBook Packages: Springer Book Archive